[PDF] Top 20 Current clinical trials testing the combination of immunotherapy with radiotherapy
Has 10000 "Current clinical trials testing the combination of immunotherapy with radiotherapy" found on our website. Below are the top 20 most common "Current clinical trials testing the combination of immunotherapy with radiotherapy".
Current clinical trials testing the combination of immunotherapy with radiotherapy
... Another approach for enhancing anti-tumor immunity is vaccination through presentation of tumor antigens on recombinant viral vectors. The combination of tumor vac- cines with RT has shown promise in preclinical ... See full document
20
Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer
... these clinical tri- als to develop preclinical models that can be used to optimize the treatment ...phase clinical trials ...the clinical trials described above, we hypothesized that ... See full document
8
Radiation and immunotherapy: a synergistic combination
... Fractionation of RT regimens. When priming the immune system, is it better to use conventional fractionation or hypofractionated regimens? Historically, RT has been administered in daily frac- tions of approximately ... See full document
9
Original Article Efficacy of autologous tumor antigen sensitized dendritic cells in combination with cytokine induced killer cells on ovarian cancer immune therapy
... and radiotherapy, have the danger of me- tastasis, recurrence, normal tissue and immune function ...its immunotherapy effect on ovarian ...in combination with cytokine induced CIK combined passive ... See full document
7
A phase I/II trial of fixed dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
... that radiotherapy instigates a sys- temic anti-cancer immune ...the combination of anti-PD1 treatment with radiotherapy could work synergistically and raise response rates in patients with metastatic ... See full document
9
<p>Durable Response After Combination Of Concurrent Chemoradiotherapy And Anti-PD-1 Therapy In HER2-Negative Advanced Gastric Adenocarcinoma: A Case Report</p>
... the combination of concurrent radiochemotherapy and immune checkpoint blockade ...the combination of concurrent SOX regimen chemotherapy, stomach radiotherapy and PD-1 antibody immunotherapy ... See full document
8
Combination immunotherapy: a road map
... escalation trials afford the flexibility to explore various dose combinations of the respective agents by alternating the increases in dosing of each agent during dose ...the clinical activ- ity and/or ... See full document
15
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
... cancer immunotherapy and the development of multiple checkpoint inhibitors have dramatically changed the current landscape of cancer ...and clinical data have shown that oncolytic vectors can induce ... See full document
13
Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
... the combination of WT1 plus gemcitabine was associated with a superior PFS, as compared to gemcitabine alone (133 versus 76 days; HR = ...in combination with gemcita- bine versus gemcitabine alone, as ... See full document
12
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology
... concurrent clinical trials investigating various immunotherapy strategies in ...during immunotherapy as opposed to traditional ...The immunotherapy RANO (iRANO) criteria were published ... See full document
20
CURRENT EUROPEAN REGULATION PERSPECTIVE ON PEDIATRIC CLINICAL TRIALS
... Teleconference with the applicant is also carried out on any issue. Oral explanation meetings are also possible. If major changes occurs during day 30 and day 60, these major issues are difficult to clarify during ... See full document
5
<p>Clinical Utility of Rush Venom Immunotherapy: Current Status</p>
... These data take into account the whole treatment with immunotherapy and do not focus on the build-up phase. As explained above, several schedules are used in the build-up phase to reach the maintained dose. The ef ... See full document
10
What constitutes a "clinical trial"?: A survey of oncology professionals
... a clinical trial as being "treatment based; including surgery, systemic chemother- apy and radiation ...therapy. Trials for cancer prevention, screening or diagnosis are not ...regarding trials ... See full document
6
Systemic use of tumor necrosis factor alpha as an anticancer agent
... Asparagine-glycine-arginine conjugated to the N-terminus of TNF-α (NGR-TNF-α) specifically binds the aminopeptidase N (CD13) of tumor vasculature [87]. CD13 is required for the pathological development of vasculature in ... See full document
13
Peanut immunotherapy
... peanut immunotherapy was attempted in a small study in 1992, where an initial rush injection schedule was administered, followed by once-weekly maintenance injections for 4 ...subcutaneous immunotherapy to ... See full document
6
Review Article Efficacy and safety of denosumab and teriparatide treatment for osteoporosis: a systematic review and meta-analysis
... that combination treatment using teriparatide and bisphospho- nates showed no additive effects on improving the BMD of patients with osteoporosis [15, 16, 25], but combination therapy of teriparatide and ... See full document
8
Intratumoral injection of IFN alpha dendritic cells after dacarbazine activates anti tumor immunity: results from a phase I trial in advanced melanoma
... DC-based immunotherapy associated with standard ...and clinical responses, while three patients were excluded because of a rapid disease progression (two patients received two injections of DCs and one ... See full document
13
Noncoding RNAs in cancer therapy resistance and targeted drug development
... to radiotherapy in breast cancer ...to radiotherapy both in vitro and in vivo through the inactivation of EMT and CSCs by modulating the miR-1/SLUG axis ...affect radiotherapy responses ... See full document
15
Proton Beam Therapy - the Challenges of Delivering High-quality Evidence of Clinical Benefit.
... UK, radiotherapy clinical trials and radiotherapy research is co-ordinated by the National Cancer Research Institute funded Clinical and Radiotherapy Translational group (CTRad) ... See full document
14
Research ethics committees: agents of research policy?
... for trials with interventions which can be used without informed consent in everyday ...For trials comparing different treatment poli- cies (pragmatic trials), providing information to and gain- ing ... See full document
5
Related subjects